US House passes crucial bill on defence co-operation with India

Agencies
July 15, 2017

Jul 15: The US House of Representatives has passed a dollor 621.5 billion defence expenditure bill that proposes to advance defence cooperation with India.usindia

An amendment in this regard, moved by Indian-American Congressman Ami Bera, was adopted by a voice vote by the House as part of the National Defense Authorisation Act (NDAA) 2018, beginning October 1 this year. NDAA-2018 was passed by the House 344-81.

The India-related amendment passed by the House requires the Secretary of Defence, in consultation with the Secretary of State, to develop a strategy for advancing defence cooperation between the United States and India.

"The United States is the worlds oldest democracy and India is the world's largest democracy. It is vitally important to develop a strategy that advances defence cooperation between our two nations," Bera said.

"I am grateful this amendment passed and look forward to the Defence Departments strategy that addresses critical issues like common security challenges, the role of partners and allies, and areas for collaboration in science and technology," he said.

Jul 15: The US House of Representatives has passed a dollor 621.5 billion defence expenditure bill that proposes to advance defence cooperation with India.

An amendment in this regard, moved by Indian-American Congressman Ami Bera, was adopted by a voice vote by the House as part of the National Defense Authorisation Act (NDAA) 2018, beginning October 1 this year. NDAA-2018 was passed by the House 344-81.

The India-related amendment passed by the House requires the Secretary of Defence, in consultation with the Secretary of State, to develop a strategy for advancing defence cooperation between the United States and India.

"The United States is the worlds oldest democracy and India is the world's largest democracy. It is vitally important to develop a strategy that advances defence cooperation between our two nations," Bera said.

"I am grateful this amendment passed and look forward to the Defence Departments strategy that addresses critical issues like common security challenges, the role of partners and allies, and areas for collaboration in science and technology," he said.

Cooperation enhances ability to meet security challenges

"Cooperation between the US and India enhances our own defence and our ability to meet the evolving security challenges of the 21st century," Bera said.

Following the passage of the National Defence Authorisation Act, the Secretary of Defence and Secretary of State have 180 days to develop a strategy for advancing defence cooperation between the United States and India. NDAA needs to be passed by the Senate before it can be sent to the White House for the US President Donald Trump to sign into law.

As passed by the House, NDAA-2018 asks the State Department and the Pentagon to develop a strategy that addresses common security challenges, the role of American partners and allies in India-US defence relationship, and role of the defence technology and trade initiative.

It also asks them to address how to advance the communications interoperability and security memorandum of agreement and the basic exchange and cooperation agreement for geospatial cooperation. The previous NDAA-2017 had designated India as a major defence partner which brings India at par with closest American partners in terms of defence trade and technology transfer.

Cooperation enhances ability to meet security challenges

Meanwhile, a senior defence official yesterday said that India and US defence relationship is on positive track.

"We look at the global order, and when we look at the evolving security environment within Asia, India's rise and role [is] evolving, [and] we see the United States and India increasingly viewing the region in the same way, and our interests are very much aligned," said Cara Abercrombie, Deputy Assistant Secretary of Defence for South and Southeast Asia.

Addressing a New York audience, she said the relationship creates a high level of dialogue in the Pentagon on a range of issues.

"This is all rooted in when we look at the region and [what] we share. We have the same [aerial] security interests, the same counter-proliferation, counter-piracy, and counter- terrorism [interests]," she added.

"We have the same interests in upholding this international system that upholds the rule of law that favours freedom of navigation, open sea lanes of communication, and freedom of over flight. Those are values that are critically important to the United States and India to our economic prosperity and to our access in the region," Abercrombie said during a panel discussion at the 2017 Global Business Forum in New York City.

"Cooperation between the US and India enhances our own defence and our ability to meet the evolving security challenges of the 21st century," Bera said.

Following the passage of the National Defence Authorisation Act, the Secretary of Defence and Secretary of State have 180 days to develop a strategy for advancing defence cooperation between the United States and India. NDAA needs to be passed by the Senate before it can be sent to the White House for the US President Donald Trump to sign into law.

As passed by the House, NDAA-2018 asks the State Department and the Pentagon to develop a strategy that addresses common security challenges, the role of American partners and allies in India-US defence relationship, and role of the defence technology and trade initiative.

It also asks them to address how to advance the communications interoperability and security memorandum of agreement and the basic exchange and cooperation agreement for geospatial cooperation. The previous NDAA-2017 had designated India as a major defence partner which brings India at par with closest American partners in terms of defence trade and technology transfer.

'India-us defence ties on positive track'

Meanwhile, a senior defence official yesterday said that India and US defence relationship is on positive track.

"We look at the global order, and when we look at the evolving security environment within Asia, India's rise and role [is] evolving, [and] we see the United States and India increasingly viewing the region in the same way, and our interests are very much aligned," said Cara Abercrombie, Deputy Assistant Secretary of Defence for South and Southeast Asia.

Addressing a New York audience, she said the relationship creates a high level of dialogue in the Pentagon on a range of issues.

"This is all rooted in when we look at the region and [what] we share. We have the same [aerial] security interests, the same counter-proliferation, counter-piracy, and counter- terrorism [interests]," she added.

"We have the same interests in upholding this international system that upholds the rule of law that favours freedom of navigation, open sea lanes of communication, and freedom of over flight. Those are values that are critically important to the United States and India to our economic prosperity and to our access in the region," Abercrombie said during a panel discussion at the 2017 Global Business Forum in New York City.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 24,2020

Toronto, Apr 25: Canadian Prime Minister Justin Trudeau on Thursday (local time) announced a new CAD 1.1 billion package supporting vaccine research and clinical trials as well as expanded testing capacity.

"We are putting in place an additional CAD 1.1 billion dollars for a national medical and research strategy to address COVID-19," Trudeau said during his daily novel coronavirus pandemic briefing on Thursday.

"This plan has three pillars -- research on vaccines and other treatments, support for clinical trials and expanding national testing and modelling," he added.

Trudeau pointed out that CAD 82 million of the total sum will be directed to the development of a vaccine and treatments against the virus, while CAD 471 million will go towards supporting clinical trials.

A further CAD 249 million is being allocated for expanding testing capacity and modelling, the Prime Minister added.

According to Trudeau, this funding will be allotted to a new "immunity task force" commissioned with conducting serology testing -- blood tests looking for the presence of antibodies indicative of exposure to the virus and subsequent immune response.

He said the taskforce, comprising the country's top medical experts, including Chief Public Health Officer Dr Theresa Tam, will test at least a million Canadians over the next two years.

The funding announced today comes in addition to the CAD 200 million committed for COVID-19-related research on March 11.

Trudeau has repeatedly stressed the daily constraints that much of the population is adhering to will be the new normal until a vaccine is developed.

As of Thursday, Canada has confirmed a total of 40,824 COVID-19 cases since the onset of the outbreak, out of which more than 2,000 have proven to be fatal, according to the latest figures from the country's public health agency.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Melbourne, Apr 10: Scientists have identified six drug candidates from more than 10,000 compounds that may help treat COVID-19.

The research, published in the journal Nature, tested the efficacy of approved drugs, drug candidates in clinical trials and other compounds.

"Currently there are no targeted therapeutics or effective treatment options for COVID-19," said Professor Luke Guddat from the University of Queensland in Australia.

"In order to rapidly discover lead compounds for clinical use, we initiated a programme of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus," Guddat said.

The project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication, the researchers said.

This makes it an attractive drug target for this virus, and as people don't naturally have this enzyme, compounds that target it are likely to have low toxicity, they said.

"We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus. If the amount is small, then we have a promising compound for further studies," said Guddat.

After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.

"We're particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer," Guddat said.

Researchers said compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.

"With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future," Guddat said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 18,2020

Beijing, Feb 18: A hospital director at the epicentre of China's virus epidemic died on Tuesday, state media said, the latest medical worker to fall victim to the new coronavirus spreading across the country.

The COVID-19 virus, which is believed to have originated in Wuhan late last year, has infected more than 72,000 people and killed nearly 1,900.

Liu Zhiming, the director of Wuchang Hospital in Wuhan, died Tuesday morning after "all-out rescue efforts failed," state broadcaster CCTV reported.

China said last week that six medical workers had died from the virus, while 1,716 have been infected.

Liu's death was initially reported by Chinese media and bloggers shortly after midnight on Tuesday -- but the stories were later deleted and replaced with reports that doctors were still trying to save him.

After initial reports of his death were denied, the hospital told AFP on Tuesday morning that doctors were giving him life-saving treatment.

Liu's death has echoes of that of Wuhan ophthalmologist Li Wenliang, who had been punished by authorities for sounding the alarm about the virus in late December.

Li's death prompted a national outpouring of grief as well as anger against the authorities, who were accused of mishandling the crisis.

People took to social media to mourn Liu on Tuesday, with many users on the Twitter-like Weibo platform drawing critical comparisons between Liu's death and Li's.

In both cases their deaths were initially reported in state media posts -- later deleted -- and their deaths denied, before being finally confirmed again.

"Has everyone forgotten what happened to Li Wenliang? They forcefully attempted resuscitation after he died," one Weibo commenter wrote.

Another commenter said, Liu "already died last night, (but) some people are addicted to torturing corpses".

A hashtag about Liu's death had 29 million views by Tuesday afternoon.

Doctors in Wuhan face shortages of masks and protective bodysuits, with some even wearing makeshift hazmat suits and continuing to work despite showing respiratory symptoms, health workers have told AFP.

Hubei province and its capital Wuhan have been the hardest hit by the virus, accounting for nearly 1,800 of the deaths from the virus so far.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.